Process for the preparation of 6-(perfluoroalkyl) uracil compounds from
申请人:American Cyanamid Company
公开号:US06140270A1
公开(公告)日:2000-10-31
An improved process for the preparation of 6-(perfluoroalkyl)uracil compounds having the structural formula I ##STR1## from 2-(N,N-disubstituted)amino-4-(perfluoroalkyl)-1,3-oxazin-6-one compounds having the structural formula II ##STR2##
Process for the preparation of 6-(perfluoroalkyl) uracil compounds form urea compounds
申请人:American Cyanamid Company
公开号:US06191275B1
公开(公告)日:2001-02-20
An improved process for the preparation of 6-(perfluoroalkyl)uracil compounds having the structural formula I
from urea compounds having the structural formula II
Processes and intermediate compounds for the preparation of 2-(N,N-disubstituted) amino-4-(perfluoroalkyl)-1, 3- oxazin-6-one and 6-(perfluoroalkyl) uracil compounds
申请人:BASF Aktiengesellschaft
公开号:US06355796B1
公开(公告)日:2002-03-12
An improved process and intermediate compounds for the preparation of 2-(N,N-disubstituted)amino-4-(perfluoroalkyl)-1,3-oxazin-6-one compounds having the structural formula I
and an improved process for the preparation of 6-(perfluoroalkyl)uracil compounds having the structural formula V
Benzisothiazoles useful for treating or preventing HCV infection
申请人:Hong Hui
公开号:US20060229294A1
公开(公告)日:2006-10-12
The present invention relates to benzisothiazoles and pharmaceutical compositions thereof that inhibit replication and/or proliferation of HCV virus. The present invention also relates to the use of the benzisothiazoles and pharmaceutical compositions comprising the compounds to treat or prevent HCV infections.
Process for the preparation of 6-(perfluoroalkyl) uracil compounds from carbamate compounds
申请人:BASF Aktiengesellschaft
公开号:US06313295B1
公开(公告)日:2001-11-06
An improved process for the preparation of 6-(perfluoroalkyl)uracil compounds having the structural formula I
from carbamate compounds having the structural formula II